Hello, everyone, and nice to see you again. We hope the weekend was relaxing and restorative. Now, of course, the routine of meetings and deadlines resumes. To cope, yes, we are brewing the mandatory cup of stimulation. Our flavor today is Rain Forest Nut. Please join us, or grab a bottle of water, if you prefer. Meanwhile, here are some tidibits from around the world. Have a successful day and stay in touch...
Novartis Begins Constructing New Plant In Russia (Pharma Biz)
Glaxo Probes Augmentin Production After China Orders Recall (The Guardian)
How Pfizer Hopes To Repair Its Drug Development (Xconomy)
Companies Push For Tax Break On Foreign Cash (New York Times)
Chemical Seepage At Old Pfizer Site Angers Activists (MyCentralJersey)
J&J Recalls Risperdal Bottles Due To Odors (Associated Press)
Indian Court Warns Pharma Over Using Deceptive Product Names (Economic Times)
Regeneron Wins FDA Panel Backing For Eye Drug (Bloomberg News)
Pennsylvania Court Says Too Late To File Claims Against Glaxo (Legal Intelligencer)
Watson Is Temporarily Barred From Selling Seasonique (Bloomberg News)
EDITOR’S NOTE: Please check this post for updates throughout the morning
steaming coffee thx to dleggett on flickr
1 Comment
Don't like seeing advertisements when accessing.